Global Human Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Human Vaccines Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A vaccine is a biological substance designed to protect humans from infections caused by bacteria and viruses. Vaccines are also called immunizations because they take advantage of human natural immune system’s ability to prevent infectious illness.

Market Overview:

The latest research study on the global Human Vaccines market finds that the global Human Vaccines market reached a value of USD 104412.45 million in 2022. It’s expected that the market will achieve USD 51970.2 million by 2028, exhibiting a CAGR of -10.98% during the forecast period.

Viral epidemic needs to make effective treatments and vaccines quickly. Billions of doses of vaccines are needed worldwide, and vaccine production needs to be carried out at a certain scale and speed while maintaining consistent high quality standards.

The company's ability to rapidly produce and manufacture medicines and vaccines and ensure large-scale supply is based on experience and expertise. In order to meet the challenge of epidemic situation, the cooperation among pharmaceutical companies, governments and international organizations is very important.

Usually, with the development of drugs and vaccines from clinical to regulatory approval, their production will increase. The urgent and immediate needs during the epidemic caused the scientific, clinical and production teams to work in parallel to achieve the highest efficiency.

Global demand for raw materials may be affected. The global existence of the virus also means operational restrictions, such as travel restrictions of people and materials, and personnel challenges in terms of employees' illness and self-isolation needs.

Safety and Controversy

Since the vaccine came out, its safety has been paid much attention, so the controversy is not new. Over the years, some vaccines have been recalled or related to other health conditions. Unverified information may lead others to think that vaccines do more harm than good, which is not the case. Although vaccinations have some risks, they are absolutely safe. The recent public controversy involves MMR vaccine and its association with autism, a developmental disorder. There was one, now retracted, study that showed this. However, since then, many studies have proved that there is no connection, but the negative impact around MMR security still exists. Human Vaccines industry is affected by security disputes.

Human Vaccines will continue to be a necessary means to prevent infectious diseases with high mortality and few treatment options.

Human vaccine is one of the most cost-effective health interventions against pathogens and other infectious diseases, saving millions of lives every year and improving the quality of life of countless others. And vaccination has effectively prevented many fatal or debilitating infectious diseases, which is regarded as one of the greatest achievements in the field of public health. Undoubtedly, vaccines will continue to be a necessary means to prevent infectious diseases with high mortality and few treatment options. At the same time, with the continuous development of vaccine research and development, vaccines can be used not only to prevent infectious diseases, but also to prevent and even treat non-communicable diseases such as cancer, and this trend is becoming increasingly obvious.

Region Overview:

In global comparison, a significant portion of the revenue was generated in Asia Pacific (38.09% in 2022).

Company Overview:

Pfizer is one of the major players operating in the Human Vaccines market, holding a share of 14.01% in 2022.

Pfizer

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.

Sinovac

SINOVAC Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government stockpiling program. The Company is developing several new products including a Sabin-strain inactivated polio vaccine and combined vaccines.
SINOVAC primarily sells its vaccines in China, while also exploring growth opportunities in international markets.

Segmentation Overview:

By type, COVID-19 segment accounted for the largest share of market in 2022.

Pneumococcal

The pneumococcal vaccine protects against serious and potentially fatal pneumococcal infections.

Influenza

Influenza (flu) is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It can cause mild to severe illness, and can lead to hospitalization and death.

Hepatitis

Hepatitis means inflammation of the liver. Hepatitis B is a liver infection, which can have serious consequences. Vaccination can prevent Hepatitis B.

HPV

Cervical cancer is always caused by the human papilloma virus (HPV). There are many variants of this virus. The HPV vaccine protects against the two variants that together are accountable for 70% of all cases of cervical cancer.

Meningococcal

Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis.

Rotavirus

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children.

Measles

Measles vaccine protects against becoming infected with measles.

Typhoid

Typhoid fever is a disease caused by Salmonella serotype Typhi bacteria. Typhoid vaccines are vaccines that prevent typhoid fever.

Combination

A combination vaccine is defined as a mixture of individual vaccines before administration in vivo so that the multiple vaccines are administered in an individual injection.

COVID-19

COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2).

Application Overview:

By application, the Adult Vaccines segment occupied the biggest share from 2017 to 2022.

Pediatric Vaccines

Pediatrics involves children from birth to adulthood.

Adult Vaccines

Adulthood, the period in the human lifespan in which full physical and intellectual maturity have been attained.

Key Companies in the global Human Vaccines market covered in Chapter 3:

Valneva
Sanofi Pasteur
Merck
Seqirus
Sinovac
Serum Institute of India
Panacea Biotec
Biological E. Limited
Emergent Biosolutions
Pfizer
Bavarian Nordic
GlaxoSmithKline (GSK)
AstraZeneca
Mitsubishi Tanabe Pharma
Bharat Biotech

In Chapter 4 and Chapter 14.2, on the basis of types, the Human Vaccines market from 2018 to 2029 is primarily split into:

Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
COVID-19
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Human Vaccines market from 2018 to 2029 covers:

Pediatric Vaccines
Adult Vaccines
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)